HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 2.92
Day range
kr 2.81 - kr 2.97
Year range
kr 2.00 - kr 17.98
Market cap
271.53M SEK
Avg Volume
1.06M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.79M | -16.73% |
Net income | -21.73M | -2.42% |
Net profit margin | — | — |
Earnings per share | -0.42 | 33.33% |
EBITDA | -17.77M | 16.74% |
Effective tax rate | 0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 95.72M | 145.48% |
Total assets | 161.41M | 51.74% |
Total liabilities | 53.83M | 146.90% |
Total equity | 107.58M | — |
Shares outstanding | 96.08M | — |
Price to book | 2.60 | — |
Return on assets | -34.70% | — |
Return on capital | -41.19% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -21.73M | -2.42% |
Cash from operations | -17.04M | 45.08% |
Cash from investing | — | — |
Cash from financing | 83.15M | 35,633.76% |
Net change in cash | 65.94M | 309.29% |
Free cash flow | 372.25K | 101.55% |
About
Founded
1999
Website
Employees
13
